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Occupational asthma (OA) can be defined as variable airways narrowing causally related to exposure in the
working environment to airborne dusts, gases, vapours or fumes. There are many agents in the work-place that can
induce asthma or cause substantial deterioration in pre-existing asthma. It has been estimated that 5–15% of adult-
onset asthma can be attributed to occupational exposures. Hence adult patients, especially those with new-onset
asthma, must be investigated with regard to occupational risk factors for disease. The prognosis for OA is improved
if the causal exposure is controlled either by controlling the exposure at the workplace or by moving the patient out
of the workplace.
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In the past, interest in occupational lung diseases has
largely focused on conditions that aect the lung parench-
yma, but in recent years there has been a growing interest in
the occupational causes of airways disease. This recognizes
the shifting epidemiology of occupational lung disease. In
the industrialized world, occupational asthma (OA) is now
probably the most frequent occupational respiratory
disorder, and this pattern is likely to spread worldwide.
No generally accepted definition of OA has been
established. A commonly cited clinical definition, however,
is ‘variable airways narrowing causally related to exposure
in the working environment to airborne dust, gases, vapo-
;urs or fumes’ (1). This is an intentionally broad definition,
including both persons with new-onset asthma caused by
the working environment and persons in whom pre-existing
asthma has become more manifest due to aggravation
caused by occupational factors. It is also important to note
that OA can be, to a considerable extent, a medico-legal
diagnosis. In that context, diagnostic criteria are often
adjusted to national legislation (2). For example, specificReceived October 1999 and accepted in revised form 3 January
2000.
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0954-6111/00/060529+07 $35?00/0inhalation challenge in the diagnosis of OA has been used
predominately in jurisdictions where insurance authorities
require such testing in order to accept the diagnosis of OA.
A definition of OA that can be used in clinical practice or
for certain epidemiological purposes is presented in Table 1.
It is partly based on a U.S. definition used in a surveillance
program for OA (3). It also includes work-related asthma,
i.e. pre-existing asthma that is substantially aggravated by
occupational exposure.
Exposure assessment is of great importance in diagnosing
OA. In some work-places, occupational exposures may be
very complex requiring detailed assessment with an
industrial hygiene consultant, but simple questioning may
elicit the suspect agent in many work practices. For
example, trimellitic acid anhydride should be suspected as
a potential exposure whenever epoxy glues are reported to
be used. In cases where a single high level irritant exposure
has triggered new-onset asthma, the so called reactive
airways dysfunction syndrome (RADS), an exposure
history should be clear cut (4). For occupational asthma,
suspected work-practices often include use of two-part
chemical systems that must be mixed just prior to use; dusty
activities, especially including exotic woods; foodstus;
animal handling; working with powdered latex gloves; or
exposure to any chemical whose warning label identifies
sensitization as a potential hazard.
A prerequisite for a causal relationship between exposure
and asthma is that the exposure has occurred before the
start or before the substantial aggravation of the condition.# 2000 HARCOURT PUBLISHERS LTD
TABLE 1. Working definition of occupational asthma. This definition would include both new occupational asthma secondary
to sensitization or irritant exposure and work-related exacerbations of a pre-existing disease. Modified from Matte et al. (3)
1. Definite asthma
and
2. Temporally related occupational exposure to an agent, process or environment known to cause asthma or to substantially
aggravate an existent asthma
or
3. An association between asthma and work, meaning at least one of following:
3.1 Temporal relation between symptoms of asthma and work
or
3.2 Significant work-related changes of FEV1 or PEF
or
3.3 Significant work-related changes in airways responsesiveness as measured by non-specific inhalation challenge
or
3.4 Positive response to inhalation provocation testing with an agent to which the patient is exposed at work
or
3.5 Onset of asthma, or substantial aggravation of asthma, following shortly after a high exposure to airway irritants
530 K. TORE´N ET AL.Asthma occurring on first exposure is usually indicative of
pre-existent disease whereas asthma occurring after a
symptom-free ‘latent’ interval is more consistent with an
occupational activity. Nevertheless, asthma induction can
either occur quite rapidly or over a period of several years.
It is important to ask the patient carefully about the timing
of the first signs of asthma symptoms. For instance,
asthmatic symptoms can occur following a change of job,
after introduction of new materials into the work-place, or
after a new process is employed. It is important to note that
nasal symptoms may occur as a harbinger of illness, prece-
ding respiratory symptoms by many months or years (5).
Other indicators of OA are that asthma symptoms occur
in the evening or at night following working days, and may
be lessened during weekends or holidays. These distinctions
may be blurred, however, with increasing length of
exposure. Moreover, ongoing asthma may continue after
removal from exposure, especially if the condition is
advanced (6).
Serial measurements of FEV1 have been proposed, but
exposure-related changes over a working day may be
dicult to distinguish because of the normal diurnal
variation of FEV1. Serial recordings of peak expiratory
flow (PEF) over a period of several weeks, when the patient
is working and o work, have been found to be useful in
demonstrating that a work-place exposure is associated
with asthma (7). Occupational exposure may induce a
gradual fall in the PEF, and withdrawal from the exposure
may lead to gradual improvement in the PEF-values.
Measuring PEF is very dependent on the cooperation of the
patient, but this problem may be overcome by using
computerized peak flow meters (8–9).
Serial measurement of non-specific bronchial hyper-
responsiveness (NSBH) at work and away from work has
also been recommended in evaluation of potential OA (10).
NSBH should be evaluated on a working day after a
minimum period of 2 weeks at work, and compared to
NSBH after a period o work of longer than 2 weeks. A
change of at least two dose-steps is usually required for achange in NSBH to be considered clinically significant. The
NSBH may be normal if the worker not has been recently
exposed (11).
Specific inhalation challenge testing has been proposed as
the ‘gold standard’ in the diagnosis of OA related to specific
sensitization (12–13). However, an important disadvantage
in its use in routine clinical diagnosis is that specific
laboratory inhalation challenge tests may have low
sensitivity, i.e. cases with true OA have negative tests.
The most likely reason for false-negative tests is that the
wrong agent or too low a dose has been used. This is
particularly relevant when complex processes or transient
intermediates are the causative agents. A negative test may
also occur if the subject has been away from work for a
long period. Specific inhalation challenge is not relevant
when the work-place exposure is a non-specific irritant, for
example sulfur dioxide or acid aerosols. Finally, specific
challenges may be dangerous if a powerful response is
induced.
Epidemiology
From the available literature it can be estimated that 5–
15% of adult asthma may be caused by occupational
exposures (14–17). The frequency of occupational asthma
depends upon many factors, including susceptibility to
respiratory sensitization, the character of the industries in
any given area, the number of people who are at risk, and
the exposure conditions in the workplaces involved. Our
limited knowledge about the occurrence of OA in the
general population is based on surveillance schemes, on
ocial statistics for occupational diseases and a few
population-based epidemiological studies.
A system for the surveillance of work-related and
occupational respiratory disease (SWORD) has existed in
Great Britain since 1989. From that system, in 1992, an
overall incidence of 37 cases of OA per million of the
working population was reported (18). During the period
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(SHIELD) in the West Midlands area of Great Britain
estimated a rate of 43 cases of OA per million workers (19).
Based on information from the Finnish Registry of
Occupational Diseases, the overall incidence of OA in
1992 was 153 cases per million workers (18). The highest
incidences in that registry were found among bakers, spray
painters and electronic assemblers. In a Swedish Registry of
self-reported occupational diseases, the annual reporting
rate of OA for 1990–1992 was 80 cases per million, with the
highest rates among male bakers, male welders and female
chemical and plastic production workers (20). The rather
large dierences between the Finnish and Swedish registers
compared to the British ones are probably due to under-
reporting in the British systems, rather than dierent work
conditions. The British systems are based on voluntary
reporting by certain physicians, whilst in Finland it is
mandatory for all physicians to report all occupational
diseases, and the Swedish system is based on reporting by
the subject himself. These dierences underscore the
caution with which frequency data for work-related asthma
must be interpreted.
Occupational exposures causing
asthma
About 250–300 factors (some specific and others less well-
defined) encountered at work have been reported to cause
OA (21). This number will continue to increase as new
processes are continuously introduced into industry. In one
commonly used classification scheme, the causes of OA can
be divided into three major categories (Table 2) (21). Most
high-molecular weight agents (HMW) (5 kDa) induce
asthma through an IgE-mediated mechanism. The high-
molecular weight agents are mainly proteins that can act asTABLE 2. Selected examples of exposures causing occupational a
Type of
exposure*
Mechanism Exposure
HMW IgE-dependent Flour dust
Grain dust
Latex
Enzymes
Animals
LMW IgE-dependent Acid
Anhydrides
Reactive dy
Persulphate
Non IgE-dependent Isocyanates
Acrylates
Irritants Toxic eect Chlorine
SO2
*HMW: high molecular weight agents; LMW: low molecular wcomplete antigens, and hence induce IgE synthesis. When
these antigens are inhaled, they bind to specific IgE on the
surface of mast cells or basophils. This binding induces an
inflammatory reaction mediated by a variety of cytokines
and other pro-inflammatory mediators (22). Among
patients with HMW induced OA, IgE antibodies can be
detected either by analysing circulating IgE, e.g. RAST, or
by skin-prick testing if a suitable preparation of allergen is
available. However, many occupational allergens are not
standardized, and information on the sensitivity and
specificity of skin prick tests or intra-dermal tests is often
not available (10).
Many, but not all, low-molecular weight agents (55
kDa) (LMW) appear to induce asthma through immuno-
logical mechanisms that are still poorly characterized, but
which appear to be independent of IgE. Some low-
molecular weight agents, such as acid anhydrides, persul-
phates and isocyanates, may act as haptens and induce
asthma through an IgE-dependent mechanism. It is also
important to note that although LMW allergens are often
synthetic chemicals, naturally occuring LMW chemicals are
also agents that can cause asthma. For example, the
components in Western Red Cedar, pine rosin and green
tea, all of which can cause OA, are LMW chemicals.
Exposures that can induce OA through irritant mechan-
isms are mainly gases or vapours that cause a toxic eect on
the airways. Water solubility, and the concentration, are the
key factors for determining the site of deposition in the
respiratory tract and the clinical response to irritant
exposures. As well as asthma, toxic oedemas, brochiolitis
and rhinitis have been described after such exposures
(23). There are a substantial number of case reports
establishing that very high single exposures to irritant
agents cause asthma, also called RADS (4). A pre-requisite
for an association is that the asthma symptoms must start
within 24 h of the exposure and that non-specific bronchialsthma
Occupation
Bakers
Millers
Dentists, surgeons, nurses
Bakers, pharmaceutical industry
Biomedical research, animal handlers
Plastic and epoxy resin workers
es Textile dyers
Hairdressers
Painters
Polyurethane workers
Dental technicians, assemblers, plastic workers
Bleachery workers, household cleaners
Pulp mill workers
eight agents.
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tionally argued that recurrent exposures to lower concen-
trations of irritants can also induce OA (24,25). Although
the association may be biologically plausible, controlled
studies are lacking.
Atopy and cigarette smoking
Atopy, defined as positive skin prick test to common aero-
allergens, is associated with increased risk for OA due to
HMW agents. For instance, atopic subjects which work
with laboratory animals are more likely than non-atopics to
develop OA (26–27). Pre-existing atopy appears to be of
little relevance to the development of OA as a result of
exposure to low molecular weight agents such as isocya-
nates (28) and some organic acid anhydrides (29).
In some studies, tobacco smokers have demonstrated an
increased risk of sensitization and also of OA caused by
IgE-mediated mechanisms (2). Although the association
between smoking and sensitization is not a uniform
observation, it has been recommended to advise workers
in industries in which such a risk has been demonstrated to
refrain from smoking (2). Exposure to environmental
tobacco smoke (ETS) has been linked to asthma onset in
children (30), but there is no general acceptance of a causal
link between ETS and adult-onset asthma (31–32). How-
ever, two large epidemiological studies have found that an
increased risk of asthma was observed after exposure to
ETS at home or in the work-place (33–34). In the U.S.
study, for example, 10 years work in smoky work-places
was associated with a relative risk of 14 for asthma (34).
Specific selected exposures
WELDING
Welding refers to any process of joining pieces of metal at
joint faces that have been made soft or liquid by heat. In
soldering, metal surfaces are joined by flowing a heated
substance between them without bringing the pieces them-
selves to the melting point. Hence welding is performed at a
higher temperature than soldering. Exposure to welding
fumes implies exposure to respiratory irritants and fumes
from dierent metals such as hexavalent chromium, zinc
and aluminium (21). If the steel is painted, this further
implies exposure to combustion products from burnt paint.
Asthma has been described after welding in stainless steel
(35–36), and an increased risk of asthma amongst welders
generally has been observed in some epidemiological
studies (17,37–39) supporting a relationship between
welding in stainless steel and OA. In a review in 1991,
however, the evidence was not considered strong enough to
support a causal relationship between plain steel welding
and asthma-onset (40). Nevertheless, recent epidemiological
data suggest that plain steel welding may indeed be a
potential cause of occupational asthma (17,39).REACTIVE POLYMERS (ISOCYANATES
AND ACRYLATES)
Isocyanates are characterized by the N=C=O group
which contains two double-bonds, making them very
reactive and capable of forming plastics, adhesives or
elastomers in flexible or rigid form. The most relevant
isocyanate products are toluene diisocyante (TDI), hexam-
ethylene diisocyanate (HDI) and methylene diphenyldiiso-
cyanate (MDI). In recent years, isocyanates have been
recognized as one of the main causes of OA induced by
LMW agents (21). The risk is considered to be higher for
those diisocyanates which are more volatile at room
temperature (TDI and HDI) than for MDI or polyisocya-
nates. It is worth noting that processes generating aerosols
of MDI can provoke sensitization. If the polymerized
isocyanates are heated, the monomers can be liberated thus
exposing workers to free isocyanates. This may occur
during welding in painted steel or in plastic material
containing isocyanates. Rapid glues are used in both
industry and in health care. Most of them are based on
acrylates, cyanoacrylates and methylmethacrylates. Case
reports about asthma among workers exposed to cyanoa-
crylates was first published in the mid 1980s (41–42),
followed by a number of similar case reports.
LATEX
Natural rubber latex is obtained from the rubber treeHevea
brasiliensis and contains a polymer of polyisoprene and
dierent proteins. In recent years, IgE mediated sensitiza-
tion to latex has been recognized as a major occupational
health problem amongst healthcare workers, as well as
other workers who wear latex gloves (43). In a Canadian
study from a rubber-processing factory, the prevalence of
positive skin-prick tests to latex was 11%, and the
prevalence of OA was 6%. The powder that is used on
the gloves facilitates the spread of the latex allergen in air,
and this has been recognized as a problem in medical
centres.
ENZYMES
Enzymes are applied today in a variety of industrial
processes. Bakers constitute the largest exposure group
(45–46), but enzymes are also handled in pulp mills,
breweries, dairies and in the textile industry. Enzymes
induce asthma through an IgE mediated mechanism. The
most well-known example is the epidemic sensitization to
detergent enzymes in a British detergent powder factory in
1967 (46).
Exacerbations
This classification subsumes two dierent clinical scenarios.
Exposure at the work-place may cause further impairment
of a currently symptomatic asthma, or may trigger a relapse
of a pre-existing asthma in a subject without current
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but the literature addressing this topic is scanty.
British researchers reported that 31% of patients with
non-occupational asthma reported impairment of asthma
symptoms during weekdays as compared to 42% of
patients with occupational asthma (48), thus indicating
that workplace exposure may impair pre-existing asthma.
In a community sample of adults with asthma, the
prevalence of respiratory symptoms at work was about
20% (49). In the same study, it was reported that the
prevalence of work-associated respiratory symptoms, which
later woke the subjects at night, was about 10%. These
studies indicate that workplace exposure may cause
impairment in pre-existing asthma. However, neither
bronchial hyperresponsiveness nor lung function were
aected when 12 subjects with current asthma were exposed
to high levels of wood dust (50).
In case studies of patients with suspected work-related
asthma, subjects with pre-existing asthma seem to be at
least twice as common as in the general population (25,51–
52). The studies indicate that, in particular, irritants trigger
pre-existing asthma.
Prevention and prognosis
The most important intervention for OA is prevention. The
long-term strategy should be primary prevention which
means the reduction or elimination of harmful exposures.
This should mainly be done by changing industrial
processes, for example, substitution of non-powdered for
powdered latex gloves.
As noted previously, atopy is associated with an
increased risk for HMW-induced OA. Hence pre-employ-
ment screening of applicants to work involving laboratory
animal handling has been suggested (53). This kind of
primary prevention is quite ineective, as illustrated by the
following example. Work with laboratory animals is
associated with an increased risk for OA. In a British
study (54), it was shown that after 2 years employment 20%
of the atopics had been sensitized compared with 4% of the
non-atopics. If we assume that 200 workers will be
employed and 25% (n=50) of them are atopics, then
20% of the 50, i.e. 10 of the 50 atopics, will be sensitized.
Six of the 150 non-atopics (4% of the 150) will be
sensitized. If 200 non-atopics had been employed instead,
eight workers (4% of the 200) would have been sensitized.
This means that only 50% (8/16) of the sensitizations would
have been prevented if the atopics had been denied
employment. In other words, even if the atopic 25% of
the potential work-force had been excluded, the number of
cases of occupational allergy would only be halved.
The indicators for an unfavourable prognosis are long
duration of the exposure before asthma onset, long
duration of symptoms, the degree of airways obstruction
at the time of diagnosis and the persistence of markers of
airways inflammation in bronchioalveolar fluid or in
bronchial biopsies (55). Therefore it is extremely important
to identify subjects with OA as early as possible, and
subsequently to remove them from exposure. Promptaction will reduce the risk of ongoing symptoms, but most
patients will require drug therapy for a prolonged period.
For all practical purposes, the pharmacological treatment
of OA does not dier from the therapy of other patients
with asthma.
Conclusions
. OA is now the most common occupational lung
disease in the industrialized world.
. The diagnosis of OA includes diagnosis of both the
disease (asthma) and the causal exposure.
. Early diagnosis and removal from exposure are the
most important factors for improving the long-term
prognosis.
. Good industrial hygiene and modification of unsafe
working practices are the keys to prevention.
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